Vumerity is a medicine used to treat adults with a type of multiple sclerosis (MS) known as relapsing-remitting MS. MS is a disease in which the immune system (the body’s natural defences) malfunctions and attacks parts of the central nervous system (the brain, spinal cord and the optic nerve of the eye), causing inflammation that damages the nerves and the insulation around them. In relapsing-remitting MS, the patient has flare-ups of symptoms (relapses) followed by periods of recovery (remissions). Vumerity contains the active substance diroximel fumarate.
Therapeutic Indication
### Therapeutic indication Vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see Section 5.1 for important information on the populations for which efficacy has been established).
Therapeutic Area (MeSH)
ATC Code
L04AX07
ATC Item
dimethyl fumarate
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Diroximel fumarate (BIIB098) | N/A | diroximel fumarate (biib 098) |
EMA Name
Vumerity
Medicine Name
Vumerity
Aliases
N/A